# DESolve® X-Pand Global Post Market Registry

> **NCT02453035** · — · TERMINATED · sponsor: **Elixir Medical Corporation** · enrollment: 154 (actual)

## Conditions studied

- Coronary Artery Stenosis

## Interventions

- **DEVICE:** PTCA - Desolve Scaffold

## Key facts

- **NCT ID:** NCT02453035
- **Lead sponsor:** Elixir Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05-13
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-04-30
- **Target enrollment:** 154 (ACTUAL)
- **Why stopped:** slow enrollment due to change in worldwide scaffold usage
- **Last updated:** 2021-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02453035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02453035, "DESolve® X-Pand Global Post Market Registry". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02453035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*